A2A Member Investment Highlights
- bench-top cell and bead analysis systems
- $13 million Series C led by Fidelity Biosciences and Flagship Ventures (July 2008).
- IVF performance and viability
- $3.25 million Series A led by Venture Investors (April 2007).
- 3-dimensional machine vision
- $10+ million in MICD financings led by A2A members
- mixed-metal oxide nanopowders
- $2.4 million Series B led by A2A members
